Ayahuasca and cancer treatment

Objectives: Comprehensively review the evidence regarding the use of ayahuasca, an Amerindian medicine traditionally used to treat many different illnesses and diseases, to treat some types of cancer. Methods: An in-depth review of the literature was conducted using PubMed, books, institutional maga...

Full description

Bibliographic Details
Main Author: Eduardo E Schenberg
Format: Article
Language:English
Published: SAGE Publishing 2013-10-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/2050312113508389
id doaj-a981d2dc8237487abaf9363c9a09595f
record_format Article
spelling doaj-a981d2dc8237487abaf9363c9a09595f2020-11-25T03:17:52ZengSAGE PublishingSAGE Open Medicine2050-31212013-10-01110.1177/205031211350838910.1177_2050312113508389Ayahuasca and cancer treatmentEduardo E Schenberg0Instituto Plantando Consciencia, São Paulo, BrazilObjectives: Comprehensively review the evidence regarding the use of ayahuasca, an Amerindian medicine traditionally used to treat many different illnesses and diseases, to treat some types of cancer. Methods: An in-depth review of the literature was conducted using PubMed, books, institutional magazines, conferences and online texts in nonprofessional sources regarding the biomedical knowledge about ayahuasca in general with a specific focus in its possible relations to the treatment of cancer. Results: At least nine case reports regarding the use of ayahuasca in the treatment of prostate, brain, ovarian, uterine, stomach, breast, and colon cancers were found. Several of these were considered improvements, one case was considered worse, and one case was rated as difficult to evaluate. A theoretical model is presented which explains these effects at the cellular, molecular, and psychosocial levels. Particular attention is given to ayahuasca’s pharmacological effects through the activity of N,N -dimethyltryptamine at intracellular sigma-1 receptors. The effects of other components of ayahuasca, such as harmine, tetrahydroharmine, and harmaline, are also considered. Conclusion: The proposed model, based on the molecular and cellular biology of ayahuasca’s known active components and the available clinical reports, suggests that these accounts may have consistent biological underpinnings. Further study of ayahuasca’s possible antitumor effects is important because cancer patients continue to seek out this traditional medicine. Consequently, based on the social and anthropological observations of the use of this brew, suggestions are provided for further research into the safety and efficacy of ayahuasca as a possible medicinal aid in the treatment of cancer.https://doi.org/10.1177/2050312113508389
collection DOAJ
language English
format Article
sources DOAJ
author Eduardo E Schenberg
spellingShingle Eduardo E Schenberg
Ayahuasca and cancer treatment
SAGE Open Medicine
author_facet Eduardo E Schenberg
author_sort Eduardo E Schenberg
title Ayahuasca and cancer treatment
title_short Ayahuasca and cancer treatment
title_full Ayahuasca and cancer treatment
title_fullStr Ayahuasca and cancer treatment
title_full_unstemmed Ayahuasca and cancer treatment
title_sort ayahuasca and cancer treatment
publisher SAGE Publishing
series SAGE Open Medicine
issn 2050-3121
publishDate 2013-10-01
description Objectives: Comprehensively review the evidence regarding the use of ayahuasca, an Amerindian medicine traditionally used to treat many different illnesses and diseases, to treat some types of cancer. Methods: An in-depth review of the literature was conducted using PubMed, books, institutional magazines, conferences and online texts in nonprofessional sources regarding the biomedical knowledge about ayahuasca in general with a specific focus in its possible relations to the treatment of cancer. Results: At least nine case reports regarding the use of ayahuasca in the treatment of prostate, brain, ovarian, uterine, stomach, breast, and colon cancers were found. Several of these were considered improvements, one case was considered worse, and one case was rated as difficult to evaluate. A theoretical model is presented which explains these effects at the cellular, molecular, and psychosocial levels. Particular attention is given to ayahuasca’s pharmacological effects through the activity of N,N -dimethyltryptamine at intracellular sigma-1 receptors. The effects of other components of ayahuasca, such as harmine, tetrahydroharmine, and harmaline, are also considered. Conclusion: The proposed model, based on the molecular and cellular biology of ayahuasca’s known active components and the available clinical reports, suggests that these accounts may have consistent biological underpinnings. Further study of ayahuasca’s possible antitumor effects is important because cancer patients continue to seek out this traditional medicine. Consequently, based on the social and anthropological observations of the use of this brew, suggestions are provided for further research into the safety and efficacy of ayahuasca as a possible medicinal aid in the treatment of cancer.
url https://doi.org/10.1177/2050312113508389
work_keys_str_mv AT eduardoeschenberg ayahuascaandcancertreatment
_version_ 1724629354895376384